Skip to main content
Fresenius SE & Co. KGaA logo

Fresenius SE & Co. KGaA — Investor Relations & Filings

Ticker · FRE ISIN · DE0005785604 LEI · XDFJ0CYCOO1FXRFTQS51 F Human health and social work activities
Open in API
Filings indexed 1,398 across all filing types
Latest filing 2019-06-21 Declaration of Voting R…
Country DE Germany
Listing F FRE

About Fresenius SE & Co. KGaA

https://www.fresenius.com/

Fresenius SE & Co. KGaA is a global healthcare company that provides system-critical products and services for leading therapies for the care of critically and chronically ill patients. The company's portfolio encompasses a wide range of products and services for dialysis, hospitals, and outpatient medical care. Key offerings include intravenously administered generic drugs, biopharmaceuticals, biosimilars, clinical nutrition, and infusion therapies. Additionally, the company operates a large network of private hospitals and outpatient centers. Through its strategic investment in Fresenius Medical Care, it is a leading global provider of products and services for individuals with renal diseases.

Recent filings

Filing Released Lang Actions
Declaration of Voting Results & Voting Rights Announcements 2019
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled 'Voting Rights Announcements' and contains sections detailing the 'Notification of Major Holdings' for Fresenius SE & Co. KGaA, specifically referencing the acquisition/disposal of shares with voting rights and changes in percentage holdings by BlackRock, Inc. This directly corresponds to the definition of a notification regarding changes in significant share ownership levels, which maps to the Major Shareholding Notification code (MRQ). Although the header mentions 'Voting Rights Announcements', the content structure (reporting thresholds crossed, detailed share/instrument breakdown) is characteristic of a major holding disclosure, which is covered by MRQ in this schema, or potentially DVA if it were the final results of a vote, but here it is a holding change notification.
2019-06-21 English
Declaration of Voting Results & Voting Rights Announcements 2019
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled 'Voting Rights Announcements' and contains detailed tables reporting changes in voting rights percentages for the issuer Fresenius SE & Co. KGaA, specifically noting the acquisition/disposal of shares by BlackRock, Inc. This directly corresponds to the definition of a notification regarding changes in significant share ownership levels, which aligns best with the 'Major Shareholding Notification' category (MRQ). Although the title mentions 'Voting Rights Announcements', the content structure (reporting thresholds crossed, total positions, breakdown of holdings) is the standard format for major shareholder disclosures, which is categorized as MRQ in the provided schema, rather than DVA (which is for official results of shareholder votes).
2019-06-12 English
Exane BNP Paribas 21st European Conference
Investor Presentation Classification · 100% confidence The document is titled 'Exane BNP Paribas 21st European Conference' and is dated 'Paris, 12 June 2019'. It contains extensive slides detailing company performance, financial highlights (Q1/19), growth targets (2020-2023), and segment updates (Fresenius Medical Care, Kabi, Helios, Vamed). The content structure, including 'Safe Harbor Statement', financial tables, and segment deep dives, is characteristic of an Investor Presentation given at a conference. Since it is a presentation given at a specific conference, it fits the definition of an Investor Presentation (IP) rather than a formal regulatory filing like 10-K or a standalone Earnings Release (ER). The document length is substantial (28,519 chars), confirming it is the presentation itself, not just an announcement of one.
2019-06-12 English
Goldman Sachs Annual Global Healthcare Conference
Investor Presentation Classification · 99% confidence The document text contains multiple references to specific financial periods ('Q1/19', 'Dec. 31, 2018'), financial highlights, segment performance updates (Fresenius Kabi, Helios, Vamed), and forward-looking statements. It is structured like a presentation summarizing recent quarterly results and providing business updates. The content is too detailed and comprehensive to be a simple Earnings Release (ER) which usually contains only key highlights. It is also not a full Annual Report (10-K) as it focuses on Q1 results. The structure strongly suggests an Investor Presentation (IP) or a detailed Management Discussion and Analysis (MDA) accompanying an interim report. Given the format (slides, charts, segment breakdowns, outlook for 2020-2023), 'Investor Presentation' (IP) is the most fitting classification, as it is a presentation designed for investors detailing performance and strategy, often released around the time of an Interim Report (IR). Since the document is a presentation deck, IP is preferred over IR.
2019-06-11 English
Deutsche Bank – dbAccess Berlin Conference
Investor Presentation Classification · 100% confidence The document is a presentation titled 'dbAccess Berlin Conference' dated June 2019. It contains detailed financial highlights, segment performance (Fresenius Kabi, Helios, Vamed), and strategic outlooks for Q1 2019. It is structured as a slide deck for investors, providing a comprehensive overview of the company's business and financial position. It is not a transcript, nor is it a formal regulatory filing or a standalone report, but rather an investor-facing presentation. Q1 2019
2019-06-06 English
Roadshow UK
Investor Presentation Classification · 99% confidence The document text contains multiple sections detailing financial performance for a specific period, explicitly titled 'Financial Review Q1/19' and 'Q1/19 Highlights'. It provides detailed segment results (Fresenius Kabi, Helios, Vamed) and consolidated Group financials for Q1/19, including sales, EBIT, and net income comparisons to the prior year. This structure, focusing on a period shorter than a full year (Quarter 1), strongly indicates a comprehensive interim financial report, which aligns with the definition of an Interim / Quarterly Report (IR). It is too detailed to be just an Earnings Release (ER) and is not an Annual Report (10-K).
2019-06-05 English

Browse filings by year

31 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.